Food News and Research

RSS

Regorafenib phase III results strongly support use in GIST

Regorafenib is effective for patients with gastrointestinal stromal tumors who have failed to respond to treatment with imatinib and sunitinib, trial results show.

29 Nov 2012

High–fructose corn syrup use linked to diabetes

Countries that have opted to use high-fructose corn syrup in their food and drink industry have a 20% higher mean prevalence of diabetes than countries that have minimal use of or do not use the sweetener.

29 Nov 2012

Suvorexant may bring help for people with insomnia

A new drug may bring help for people with insomnia, according to a study published in the November 28, 2012, online issue of Neurology, the medical journal of the American Academy of Neurology.

29 Nov 2012

Tadalafil may offer therapeutic strategy in patients with Becker muscular dystrophy

Cedars-Sinai Heart Institute researchers have found in an initial clinical trial that a drug typically prescribed for erectile dysfunction or pulmonary hypertension restores blood flow to oxygen-starved muscles in patients with a type of muscular dystrophy that affects males, typically starting in childhood or adolescence.

29 Nov 2012

Study identifies metabolic factors related to bread's beneficial effects on cardiovascular health

According to a study, daily bread consumption, especially wholemeal bread, can prevent cardiovascular disease. The study has been led by the professor Rafael Llorach, Ramon y Cajal researcher from the Department of Nutrition and Bromatology at the Faculty of Pharmacy and from the Food and Nutrition Torribera campus of the University of Barcelona.

29 Nov 2012

Pall first quarter 2013 sales decrease 3.6% to $627.6 million

Pall Corporation today reported financial results for the first quarter of fiscal year 2013 which ended on October 31, 2012.

From Pall Corporation 29 Nov 2012

FDA approves Velomedix’s IDE to expand design of VELOCITY trial for heart attack

Velomedix, Inc., a venture-backed medical device company advancing the field of therapeutic hypothermia, announced it has received Investigational Device Exemption (IDE) approval from the U.S. Food and Drug Administration (FDA) to expand the design of its VELOCITY pilot clinical trial.

29 Nov 2012

China's SFDA approves QIAGEN careHPV Test and instrument platform

QIAGEN N.V. today announced that China's State Food and Drug Administration (SFDA) has approved QIAGEN's careHPV Test and instrument platform.

From QIAGEN Manchester Limited 29 Nov 2012

Pfizer completes acquisition of NextWave Pharmaceuticals

Pfizer Inc. today announced that it has completed its acquisition of NextWave Pharmaceuticals, Inc., a privately held, specialty pharmaceutical company focused on the development and commercialization of products for the treatment of attention deficit hyperactivity disorder (ADHD).

29 Nov 2012

Link between high fructose corn syrup intake and diabetes prevalence

A new study by University of Southern California (USC) and University of Oxford researchers indicates that large amounts of high fructose corn syrup (HFCS) found in national food supplies across the world may be one explanation for the rising global epidemic of type 2 diabetes and resulting higher health care costs.

28 Nov 2012

Off label atypical antipsychotic use lacks safety and effectiveness in patients over 40

In older adults, antipsychotic drugs are commonly prescribed off-label for a number of disorders outside of their Food and Drug Administration (FDA)-approved indications - schizophrenia and bipolar disorder. The largest number of antipsychotic prescriptions in older adults is for behavioral disturbances associated with dementia, some of which carry FDA warnings on prescription information for these drugs.

28 Nov 2012

IPS examines undernourishment, efforts to reverse vitamin deficiencies

"Poverty is the leading cause of many vitamin deficiencies, especially vitamin A," and the problem is acute in sub-Saharan Africa and South Asia, where food staples such as cassava and rice are high in calories but low in nutrients, Inter Press Service reports.

28 Nov 2012

FDA grants final approval to Cobrek’s generic Luxiq foam NDA for treatment of scalp psoriasis

Perrigo Company today announced that its partner, Cobrek Pharmaceuticals, Inc., received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application (ANDA) for betamethasone valerate foam 0.12%, the generic equivalent of Luxiq Foam.

28 Nov 2012

FDA clears Avaxia’s AVX-470 IND for treatment of ulcerative colitis

Avaxia Biologics, Inc., a privately-held biotechnology company developing oral antibody drugs that act locally within the digestive tract, announced today that the US Food and Drug Administration (FDA) has cleared the Investigational New Drug (IND) application for AVX-470 for the treatment of ulcerative colitis.

27 Nov 2012

Liver disease therapies: an interview with Eric Halioua, CEO of Promethera Biosciences

Liver disease is a very broad family of diseases. There are two main categories of liver disease:

27 Nov 2012

Financial Times examines demographic, economic, policy changes affecting global food security

The Financial Times examines "a complex cocktail of demographic, economic, and policy changes that can be blamed for increased pressure on the food supply."

27 Nov 2012

Word-training program found to restore key words in some dementia patients

A simple word-training program has been found to restore key words in people with a type of dementia that attacks language and our memory for words.

26 Nov 2012

FDA grants Seattle Genetics orphan drug designation for ADCETRIS to treat mycosis fungoides

Seattle Genetics, Inc. announced today that ADCETRIS (brentuximab vedotin) has been granted orphan drug designation by the U.S. Food and Drug Administration (FDA) for the treatment of mycosis fungoides (MF). MF is the most common type of cutaneous T-cell lymphoma (CTCL).

26 Nov 2012

Stroke patients may perform better in clinical tests when offered a reward

Stroke patients who have difficulty paying attention to part of their visual field may perform better when offered a reward, a study by Imperial College London and Brunel University researchers has found.

26 Nov 2012

New way of long-term care for elders with memory impairments

Within a stone's throw from the hustle and bustle of Route 128, a revolutionary new way to provide elder care is quietly making a difference in the town of Westwood. From the outside, the White Oak Cottages may look like ordinary, modern family homes with lots of windows and skylights but what's going on inside is anything but ordinary. Their mission is to de-institutionalize long-term care by providing a real home-like environment for those with Alzheimer's, Dementia and other cognitive impairments.

23 Nov 2012

Food News and Research

Regorafenib phase III results strongly support use in GIST

High–fructose corn syrup use linked to diabetes

Suvorexant may bring help for people with insomnia

Tadalafil may offer therapeutic strategy in patients with Becker muscular dystrophy

Study identifies metabolic factors related to bread's beneficial effects on cardiovascular health

Pall first quarter 2013 sales decrease 3.6% to $627.6 million

FDA approves Velomedix’s IDE to expand design of VELOCITY trial for heart attack

China's SFDA approves QIAGEN careHPV Test and instrument platform

Pfizer completes acquisition of NextWave Pharmaceuticals

Link between high fructose corn syrup intake and diabetes prevalence

Off label atypical antipsychotic use lacks safety and effectiveness in patients over 40

IPS examines undernourishment, efforts to reverse vitamin deficiencies

FDA grants final approval to Cobrek’s generic Luxiq foam NDA for treatment of scalp psoriasis

FDA clears Avaxia’s AVX-470 IND for treatment of ulcerative colitis

Liver disease therapies: an interview with Eric Halioua, CEO of Promethera Biosciences

Financial Times examines demographic, economic, policy changes affecting global food security

Word-training program found to restore key words in some dementia patients

FDA grants Seattle Genetics orphan drug designation for ADCETRIS to treat mycosis fungoides

Stroke patients may perform better in clinical tests when offered a reward

New way of long-term care for elders with memory impairments

The future is bioengineered: Synthetic biology and global sustainability eBook

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Latest News